blog

The Impact of COVID-19 on Clinical Trials: Where are We? And Where are We Going?

By Aaron Fleishman, Director, Market Development on Tue, Jun 23, 2020 | 2 min read

 

Get the latest insights from our BBK-sponsored podcast.

As the country goes through the phases of reopening, what does that mean for the patient and site experience in clinical trials? PharmaTalkRadio’s Valerie Bowling discusses the future of clinical trials with Ray Dorsey, MD, Matt Kibby, and Craig Lipset in this feature podcast.

Topics: Clinical Trials, Pharma15 Live!, COVID-19, Matt Kibby, Craig Lipset, Decentralized Trials, Conference Forum

MythBusters Season 1 - What Did We Learn?

By Aaron Fleishman, Director, Market Development on Mon, Nov 4, 2019 | 3 min read

 

Is it true doctors are unwilling to refer their patients to clinical trials for fear of losing the patient? Will an app inherently solve your patient and site engagement problems? And speaking of engagement, there’s no way to actually define it and measure its impact, right? Over the course of 2019, BBK Worldwide launched a new initiative called Study Voices. Based off of the popular TV show on the Discovery Channel, MythBusters Study Voices was designed to debunk common myths in the clinical research industry. So, I’d like to introduce you to the BBK MythBusters team – Jessica Kim, Elizabeth Gargill, Matt Kibby, and me, Aaron Fleishman!

Topics: BBK Worldwide, Patient Engagement, Clinical Trials, Patient Experience, MythBusters

 
Subscribe To Our Blog